{"id":"https://openalex.org/W4362628604","doi":"https://doi.org/10.1158/2159-8290.22535057.v1","title":"Supplementary Table 2 from Pan-Cancer Efficacy of Vemurafenib in BRAFV600-Mutant Non-Melanoma Cancers","display_name":"Supplementary Table 2 from Pan-Cancer Efficacy of Vemurafenib in BRAFV600-Mutant Non-Melanoma Cancers","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362628604","doi":"https://doi.org/10.1158/2159-8290.22535057.v1"},"language":"en","primary_location":{"id":"doi:10.1158/2159-8290.22535057.v1","doi":"https://doi.org/10.1158/2159-8290.22535057.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2159-8290.22535057.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/2159-8290.22535057.v1","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043675371","display_name":"Vivek Subbiah","orcid":"https://orcid.org/0000-0002-6064-6837","observed_orcids":["https://orcid.org/0000-0002-6064-6837"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vivek Subbiah","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6064-6837","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049243227","display_name":"Igor J. Puzanov","orcid":"https://orcid.org/0000-0002-9803-3497","observed_orcids":["https://orcid.org/0000-0002-9803-3497"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Igor Puzanov","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042202815","display_name":"Jean\u2010Yves Blay","orcid":"https://orcid.org/0000-0001-7190-120X","observed_orcids":["https://orcid.org/0000-0001-7190-120X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jean-Yves Blay","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7190-120X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025120810","display_name":"Ian Chau","orcid":"https://orcid.org/0000-0003-0286-8703","observed_orcids":["https://orcid.org/0000-0003-0286-8703"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ian Chau","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0286-8703","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103111166","display_name":"Albert Craig Lockhart","orcid":"https://orcid.org/0000-0002-0132-5523","observed_orcids":["https://orcid.org/0000-0002-0132-5523"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Craig Lockhart","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052048627","display_name":"Noopur S Raje","orcid":"https://orcid.org/0000-0003-3066-1275","observed_orcids":["https://orcid.org/0000-0003-3066-1275"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Noopur S. Raje","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025511599","display_name":"Juergen Wolf","orcid":"https://orcid.org/0000-0001-8833-8812","observed_orcids":["https://orcid.org/0000-0001-8833-8812"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Juergen Wolf","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004300577","display_name":"Jose M Baselga","orcid":"https://orcid.org/0000-0003-1361-4063","observed_orcids":["https://orcid.org/0000-0003-1361-4063"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jos\u00e9 Baselga","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076426660","display_name":"Funda Meric\u2010Bernstam","orcid":"https://orcid.org/0000-0001-6816-6072","observed_orcids":["https://orcid.org/0000-0001-6816-6072"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Funda Meric-Bernstam","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035961942","display_name":"Jason Roszik","orcid":"https://orcid.org/0000-0002-4561-6170","observed_orcids":["https://orcid.org/0000-0002-4561-6170"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jason Roszik","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4561-6170","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082806411","display_name":"Eli L. Diamond","orcid":"https://orcid.org/0000-0001-5456-5961","observed_orcids":["https://orcid.org/0000-0001-5456-5961"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eli L. Diamond","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5456-5961","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060033755","display_name":"Gregory J. Riely","orcid":"https://orcid.org/0000-0001-5357-4313","observed_orcids":["https://orcid.org/0000-0001-5357-4313"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gregory J. Riely","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061365371","display_name":"Eric Jeffrey Sherman","orcid":"https://orcid.org/0000-0002-4960-4783","observed_orcids":["https://orcid.org/0000-0002-4960-4783"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eric J. Sherman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113882339","display_name":"Todd Riehl","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Todd Riehl","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068792374","display_name":"Bethany Pitcher","orcid":"https://orcid.org/0000-0003-0991-0716","observed_orcids":["https://orcid.org/0000-0003-0991-0716"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bethany Pitcher","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5068193017","display_name":"David Michael Hyman","orcid":"https://orcid.org/0000-0001-8150-9762","observed_orcids":["https://orcid.org/0000-0001-8150-9762"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David M. Hyman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.8086000084877014,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.8086000084877014,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.0617000013589859,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.023499999195337296,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vemurafenib","display_name":"vemurafenib","score":1.0},{"id":"https://openalex.org/keywords/braf-v600-mutation","display_name":"BRAF V600 mutation","score":0.9929999709129333},{"id":"https://openalex.org/keywords/non-melanoma-skin-cancer","display_name":"non-melanoma skin cancer","score":0.8980000019073486},{"id":"https://openalex.org/keywords/pan-cancer","display_name":"pan-cancer","score":0.8510000109672546},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.800000011920929},{"id":"https://openalex.org/keywords/drug-efficacy","display_name":"drug efficacy","score":0.546999990940094}],"concepts":[{"id":"https://openalex.org/C2776131300","wikidata":"https://www.wikidata.org/wiki/Q423111","display_name":"Vemurafenib","level":4,"score":0.8468302488327026},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6073771119117737},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5745889544487},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.4487147927284241},{"id":"https://openalex.org/C45235069","wikidata":"https://www.wikidata.org/wiki/Q278425","display_name":"Table (database)","level":2,"score":0.4312896728515625},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4204353094100952},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35209473967552185},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.34869951009750366},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.28613340854644775},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.16562700271606445},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.1161598265171051},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.11433017253875732},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09092307090759277},{"id":"https://openalex.org/C124101348","wikidata":"https://www.wikidata.org/wiki/Q172491","display_name":"Data mining","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/2159-8290.22535057.v1","doi":"https://doi.org/10.1158/2159-8290.22535057.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2159-8290.22535057.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22535057","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Table_2_from_Pan-Cancer_Efficacy_of_Vemurafenib_in_i_BRAF_i_sup_V600_sup_-Mutant_Non-Melanoma_Cancers/22535057","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/2159-8290.22535057.v1","doi":"https://doi.org/10.1158/2159-8290.22535057.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2159-8290.22535057.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4362617602","https://openalex.org/W4230044204","https://openalex.org/W4392691360","https://openalex.org/W3005155748","https://openalex.org/W2328849683","https://openalex.org/W1846586690","https://openalex.org/W2315029029","https://openalex.org/W7105662684","https://openalex.org/W4237852808","https://openalex.org/W7071961964"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2023-04-07T00:00:00"}